Model Number 20000ISM |
Device Problem
Particulates (1451)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/28/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
The event is captured by edwards lifesciences under complaint #: (b)(4).Once the product is received and evaluated, the investigation findings code will be updated.The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.
|
|
Event Description
|
Edwards received notification of a pascal precision ace procedure in the mitral position.During the procedure, a structure resembling a thrombus on echo was observed on the device after introducing it in the left atrium.The activated clotting time (act) was checked and confirmed to be within the therapeutic range.It was decided to take out the device and remove the structure with it.After the bailout, it was observed that a "white small thin structure" on the tip of the implant was no thrombus.As reported, it could not be ruled out that it came from the inner coating of the guide sheath (gs), so a new gs and implant system (is) were used.The procedure ended successfully.The is, the gs, and a sample container with the white structure were kept being sent back for evaluation.There is no report of patient harm or injury.
|
|
Manufacturer Narrative
|
The event is captured by edwards lifesciences under complaint #: (b)(4).The following sections were updated/corrected: b1, b2, b4, d4, g3, g6, h1, h2, h3, h4, h6, and h10.H10: a supplemental mdr is submitted based on corrected data and the manufacturer's device evaluation.Particulate on the patient contacting surface of the device entering the vasculature, resulting in embolization and/or infection or the risk for embolization/infection cannot be excluded.Upon further review, this is considered a serious injury, and the risk is not remote.The implant system, guide sheath, and a small container with the foreign white material were returned to edwards lifesciences for evaluation.The particulate was identified as collagen type i and determined to have been tissue from the patient.The patient's condition and procedure history do not indicate any risk of tissue tearing.Based on a review by ew representatives, the tissue most likely came from the transseptal puncture site and is an adverse event labeled in the ifu.No manufacturing non-conformances were confirmed to be related or contributed to the complaint event.Therefore, no ifu/training deficiencies were identified, and no corrective/preventative actions were required.
|
|
Manufacturer Narrative
|
The event is captured by edwards lifesciences under complaint #: (b)(4).The following sections were updated/corrected: b4, d9, g3, g6, h2, h3, h6, and h10.A preliminary evaluation of the returned particulate determined it was collagen.The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.
|
|
Search Alerts/Recalls
|
|